WCG Clinical, Inc. Share Price

Equities

WCGC

US92941R1095

Biotechnology & Medical Research

Delayed Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for WCG Clinical, Inc. -.--% -.--%
Sales 2019 413M 31.98B Sales 2020 463M 35.9B Capitalization 6.07B 470B
Net income 2019 18M 1.39B Net income 2020 -95M -7.36B EV / Sales 2019 * -
Net cash position 2019 * - 0 Net cash position 2020 * - 0 EV / Sales 2020 * -
P/E ratio 2019 *
-
P/E ratio 2020 *
-
Employees -
Yield 2019 *
-
Yield 2020 *
-
Free-Float 0%
More Fundamentals * Estimated data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - -
President 41 30/06/12
Chief Tech/Sci/R&D Officer - 31/12/17
Members of the board TitleAgeSince
Director/Board Member 56 31/12/18
Director/Board Member 47 31/12/11
Director/Board Member 66 31/12/11
More insiders
WCG Clinical Holdings Inc is a United States-based company. The Company is a provider of clinical trial solutions. It is focused on providing solutions that are designed to improve clinical research. Its solutions help biopharmaceutical companies, contract research organizations, and institutions for delivery of new treatments and therapies to patients. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.
More about the company